Golden Biotechnology Corp (4132) 國鼎生技 Revenue

Pharmaceutical Manufacturing • Tamsui District, New Taipei City, Taiwan, Province of China • 21-50 Employees

Golden Biotechnology Corp (4132) 國鼎生技 revenue & valuation

Annual revenue	$7,500,000
Revenue per employee	$215,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$24,000,000
Total funding	No funding

Key Contacts at Golden Biotechnology Corp (4132) 國鼎生技

Gibbson Tan

Regional Business Development Director

Sheng Yung Liu

Ceo

Penny Chen

Medical Director

Company overview

Headquarters	15F, No. 27-6, Sec. 2, Zhongzheng E. Rd.,, Tamsui Dist., , New Taipei City 251401, TW
Phone number	+886228086006
Website	goldenbiotech.com
NAICS	3254
Keywords	AML, Clinical Trials, Health Supplements, Pancreatic Cancer, Oncology, Cancer Treatment, NCE, Autoimmune, Alzheimer'S Disease, Cardio Vascular, Nsclc, Orphan Drug Designation, Neurodegenerative, Covid-19, New Drug Discovery
Founded	2002
Employees	21-50
Socials

Golden Biotechnology Corp (4132) 國鼎生技 Email Formats

Golden Biotechnology Corp (4132) 國鼎生技 uses 1 email format. The most common is {first name} (e.g., john@goldenbiotechlab.com), used 100% of the time.

Format	Example	Percentage
{first name}	john@goldenbiotechlab.com	100%

About Golden Biotechnology Corp (4132) 國鼎生技

Golden Biotechnology Corp. (GBC,”GoldenBiotech”) (TPEx4132) is an advanced pharmaceutical development company focused on meeting the pressing demand for effective medications among patients with critical medical needs. With over a decade of experience and technical know-how in cancer drug research and manufacturing, GoldenBiotech stands as one of the few organizations that are capable of independently developing NCEs (New Chemical Entities) as novel drugs. We possess comprehensive expertise in the complete process of drug development. GBC conducted comprehensive preclinical trials in collaboration with several internationally renowned research institutions and initiated research and multi-national, multi-center clinical trials targeting indications such as cancer, cardiovascular diseases, neurodegenerative diseases, autoimmune diseases, and COVID-19 virus infection. Our ongoing research centers around a brand-new NCE small molecule drug called Antroquinonol, which exhibits remarkable efficacy and safety. Antroquinonol has already completed several Phase 2 clinical trials, including studies on non-small cell lung cancer (NSCLC), acute myeloid leukemia (AML), pancreatic cancer, and COVID-19.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

C-Suite

Employees by Department

Golden Biotechnology Corp (4132) 國鼎生技 has 11 employees across 6 departments.

Departments

Number of employees

Funding Data

Golden Biotechnology Corp (4132) 國鼎生技 has never raised funding before.

Golden Biotechnology Corp (4132) 國鼎生技 Tech Stack

Discover the technologies and tools that power Golden Biotechnology Corp (4132) 國鼎生技's digital infrastructure, from frameworks to analytics platforms.

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

PHP

Programming languages

HSTS

Security

Open Graph

Miscellaneous

Swiper

JavaScript libraries

Bootstrap

UI frameworks

Google Analytics

Analytics

Frequently asked questions

Golden Biotechnology Corp (4132) 國鼎生技 is located in Tamsui District, New Taipei City, TW.

You can reach Golden Biotechnology Corp (4132) 國鼎生技 at +886228086006.

Golden Biotechnology Corp (4132) 國鼎生技 generates an estimated annual revenue of $7,500,000. This revenue figure reflects the company's market position and business performance in its industry.

Golden Biotechnology Corp (4132) 國鼎生技 has an estimated valuation of $24,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Golden Biotechnology Corp (4132) 國鼎生技 was founded in 2002, making it 24 years old. The company has established itself as a significant player in its industry over this time.

Golden Biotechnology Corp (4132) 國鼎生技 has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.